Inflammatory bowel disease associated arthropathy
- 28 June 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Current Reviews in Musculoskeletal Medicine
- Vol. 4 (3), 123-131
- https://doi.org/10.1007/s12178-011-9085-8
Abstract
Arthritis is the most common extraintestinal manifestation of inflammatory bowel disease (IBD) and can have a significant impact on morbidity and quality of life. IBD-associated arthropathy is considered a subtype of seronegative spondyloarthropathy, with axial, peripheral, or a combination of both joint manifestations. Peripheral arthritis is generally non-erosive and the oligoarticular variant particularly may correlate with intestinal disease activity. Axial arthritis may include inflammatory back pain, sacroiliitis, or ankylosing spondylitis, and is less likely to correlate with gastrointestinal symptoms. While there have been advances in identifying predisposing genetic factors and in elucidating pathophysiology of inflammatory bowel disease, the mechanisms surrounding the development of arthritis in IBD remain unclear. Treatment of inflammatory bowel disease is not always sufficient for control of arthritis. While treatment with biologic agents is promising, there remains a great need for larger, randomized studies to address optimal therapy of IBD associated arthropathy.Keywords
This publication has 101 references indexed in Scilit:
- Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohnʼs disease: Results from CAREInflammatory Bowel Diseases, 2012
- Association of Variants at 1q32 and STAT3 with Ankylosing Spondylitis Suggests Genetic Overlap with Crohn's DiseasePLoS Genetics, 2010
- Sacroiliitis Is Common in Crohn's Disease Patients with Perianal or Upper Gastrointestinal InvolvementGut and Liver, 2010
- The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's diseaseBMC Medical Genetics, 2010
- Peripheral Arthritis in the Course of Inflammatory Bowel DiseasesDigestive Diseases and Sciences, 2010
- Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseasesThe Journal of Experimental Medicine, 2008
- Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trialGut, 2007
- Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytesAnnals Of The Rheumatic Diseases, 2007
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseThe New England Journal of Medicine, 1999
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984